Frankfurt - Delayed Quote EUR
aXichem AB (A6X.F)
0.2220
+0.0345
+(18.40%)
At close: June 13 at 8:07:01 AM GMT+2
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Torsten Helsing | CEO & Director | 1.73M | -- | 1957 |
| Mr. Erik Lager | Chief Operations Officer | 1.08M | -- | 1975 |
| Ms. Gunilla Savring | Chief Investor Relations Officer | 663.3k | -- | 1962 |
| Mr. Lucas Altepost | VP and Chief Sales & Marketing officer | 1.57M | -- | 1967 |
aXichem AB
- Sector:
- Basic Materials
- Industry: Specialty Chemicals
- Full Time Employees:
- 7
Description
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.
Corporate Governance
aXichem AB’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available